Careers Media center Contacts

Legkolax – laxative for adults and children

Legkolax – laxative for adults and children

6 April 2017 | News

Arterium Corporation has launched a new product – Legkolax. The drug available in the form of oral powder is intended for the symptomatic treatment of constipation.

The active ingredient of Legkolax is macrogol 4000 molecule, the efficiency and safety of which have been proven by over 200 clinical trials conducted globally1. Legkolax can be used in adults as well as children of 6 months and over.

Constipation is a symptom many diseases. Literature sources indicate that about 12% of the adult population suffers from constipation and women experience it 3 times as often as men2. When consumed, Legkolax increases water retention in the intestinal lumen thereby contributing to a natural renewal of defecation urge, also improving bowel evacuation. Legkolax is neither absorbed nor metabolized – it is excreted from the body in an unchanged form. The preparation has minimal side-effects as compared to other laxatives – it does not irritate intestinal receptors and induces no bloating. Besides, its prolonged use does not lead to diarrhoea or intestinal atony.3,4,5 In addition, unlike most laxatives taken dissolved in water, Legkolax has a neutral taste.

The product is available in two dosages – 4 g and 10 g of active ingredient in 10 sachets per a package. Legkolax hits the shelves of Ukrainian pharmacies in April.

 

1 - PubMed database:

2 - Vdovichenko V. I. / Constipation: Pathogenesis, Classification, Treatment / News of Medicine and Pharmacy, #8 (362) 2011.

3 - B. Samedov et al. / Pathogenetically-grounded Therapy of Constipation Syndrome / Vrach, issue #3, 2012, pp. 15–21

4 - E. K. Baranskaya / Experience in Application of Modern Laxatives in the Treatment of Functional Constipation in Adults / Russian Journal of Gastroenterology, Hepatology, and Coloproctology, issue #5, 2010, Vol. 20, pp. 55–62. 5 - Legkolaks IMU

Media gallery
dfdrfd
PRESS KIT

Here you can find general information about the company intended for journalists and other stakeholders

MEDIA CONTACTS

For all media-related enquiries,
please contact us
e-mail: pr@arterium.ua
mob.: +38050 446 71 20, +38095 278 92 80